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Purpose: To describe the case of orbital subcutaneous emphysema who was successfully treated with
hyperbaric oxygen therapy.
Observations: Case report. Retrospective analysis of medical records and computer tomography images. A
40 years-old female, with retinal detachment who was seen at the emergency department, two weeks
after undergoing a combined procedure of pars plana vitrectomy, scleral buckle and Sulfur hexaﬂuoride
tamponade. The patient complained of pain, decrease eye movement and edema of the upper eyelid.
Clinical examination revealed periorbital crepitus. She was treated immediately with soft tissue
decompression with small-gauge needle. Orbital emphysema recurred quickly, indicating possible gas
trapped in the soft tissue. Using the US NAVY decompression protocol we were able to achieve fast
clinical improvement. The protocol was repeated in several occasions until complete resolution.
Conclusion and importance: Hyperbaric oxygen therapy is an effective treatment for orbital and peri-
orbital emphysema, due to its property of helping accelerate N2 elimination from adipose tissue.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The introduction of gas tamponade in vitreoretinal surgery is
without a doubt one of the most important contributions to the
retina specialist's surgical armamentarium [1,2]. The primary pur-
pose of using gas in retinal detachment surgery is to take advantage
of the surface tension created on the bubble's walls after being
placed on a ﬂuid-ﬁlled cavity; which produce an internal physical
blockage of the retinal tear, preventing ﬂuid from gaining access to
the subretinal space. In addition, it creates a buoyant force which
helps displacing the retina gently toward the retinal pigment




Inc. This is an open access article uSulfur hexaﬂuoride (SF6) is one the most widely used gas tam-
ponade worldwide. It is a colorless, odorless and nontoxic gas; is
ﬁve times heavier than atmospheric air and has a molecular weight
of 146 g/mol. Although it is chemically inert, it can expand 2 times
its original volume when used 100% pure into the vitreous cavity. It
has a non-expansile concentration of 18%, a half-life of 2.5 days and
a total lifespan of about 15 days [1,3,4].
As with other surgical devices, the use of SF6 tamponade has
potential adverse effects; being orbital subcutaneous emphysema
(OSE) one of them. It is characterized by the abnormal presence of
gas bubbles within the orbital and periorbital tissue [5]. Even
though most of the times is self-limited and has a benign clinical
course with spontaneous resolution in about 2 weeks; there are
more severe forms inwhere the build-up pressurewithin tissue can
cause a localized compartment syndrome with tissue destruction,
central retinal artery occlusion and irreversible vision loss if not
immediately decompresses [6e8].
Hyperbaric oxygen therapy (HOT), as deﬁned by the Undersea
and Hyperbaric Medical Society (UHMS), is a therapeutic inter-
vention in which the patient breathes almost 100% oxygennder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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surized above atmospheric pressure, usually above 1.4 ATA (abso-
lute atmospheres) [9]. The basic therapeutic principle of HOT in OSE
lies in increasing the oxygen partial pressure within tissue
(ischemia relief), which then increases the blood's oxygen carrying
capacity, leading to a decrease in circulating nitrogen. Low nitrogen
in tissue and blood stream leads to bubble shrinkage due to an
increase in the diffusion gradient of nitrogen from the gas bubble
toward the blood, decreasing the pressure within the orbit [9e11].
In the following case wewill describe the use of HOT for the ﬁrst
time in the treatment of OSE secondary to retinal detachment
surgery. A comprehensive analysis of the follow-up and clinical
outcomes will be done as well as a concise discussion about the
possible future application of HOT.2. Case report
The following case report description was approved by the local
institutional review board. Before all medical procedures described
herein, a comprehensive explanation, including the risk of doing
nothing, was conducted with the patient. The patient read and
signed individual consent forms for each procedure; including
consent for publication of personal information like medical re-
cords details and photographs.
A 40 years of age Mexican-mestizo female, with previous
medical history of congenital cataract, extracapsular cataract
extraction in OD and secondary glaucoma, currently treated with
hypotensive drops; was seen as an outpatient, complaining of sig-
niﬁcant inferior visual ﬁeld loss in the right eye since oneweek ago.
At presentation she had 20/70 vision in OU and lateral nystagmus.
Slit lamp examination was unremarkable. Fundus examination
revealed a superotemporal macula-on retinal detachment with an
evident retinal tear at 11 o'clock. The patient underwent an im-
mediate combined scleral buckle- 23 gauge pars plana vitrectomy
procedure with 18% SF6 as tamponade agent under general anes-
thesia. The platform of choice was an Accurus equipment (Alcon
Lab, Froth worth Texas, US). The 23 gauge non-valved trocars were
inserted in a two-step motion. The blade's design was the EDGE-
PLUS®, which constructs more linear wounds. The core vitrectomy,
vitreous base dissection and air-ﬂuid interchange were uneventful.
Gas was drawn from prediluted syringe, prepared by allied
personnel, few minutes before its use. The syringe is ﬁlled using a
silicon tube attached to a millipore ﬁlter, which in turn is connected
to the gas container, provided by the gas' manufacturer. The syringe
is ﬁlled with 100% pure gas and it is later diluted with room air, in
the presence of the surgeon. Although the surgeon did not partic-
ipate in the dilution process at this time, he supervised the pro-
cedure at all time.
Two days post-op, she was seen at the emergency department
complaining of pain and further visual loss in OD. Her vision was
hand motion and intraocular pressure was 36 mmHg. Slit lamp
examination showed superior and inferior eyelid edema, þ3 che-
mosis and corneal epithelial edema. Fundus examination showed
an attached retina with a patent retinal artery and gas ﬁlling the
vitreous cavity 100%. We decided to perform an anterior chamber
paracentesis and discharged the patient with topical hypotensive,
antibiotics and steroids drops.
Five days later (postsurgical day 7), she returned to our ofﬁce
complaining of severe ocular and periorbital pain and periorbital
“pufﬁness” (Fig. 1). Her vision remained hand motion. At this time,
her examinationwas remarkable for severe eyelid edema, complete
ptosis, mild proptosis, partial ophthalmoplegia and þ4 chemosis.Orbital cellulitis was suspected and therapy with empiric intrave-
nous antibiotics was started.
One week later (postsurgical day 14), the eyelid edema
increased and palpebral and periorbital crepitus was noted. Urgent
CT scan was performed using 1 mm slices with a soft tissue and
bone algorithm (Fig. 2). The study showed large amounts of gas
(palpebral, subconjunctival, retrobulbar and compressing the optic
nerve and causing exophthalmus) in the orbit and in anterior
chamber. There were no evidence of gas in the vitreous cavity,
however, the retina remained attached.
Surgical decompression with ﬁne needle insertion and aspira-
tion along with scleral buckle removal was done immediately. No
gas leakage was detected at this time. After surgery, the patient
recover partially, regaining ocular motility and less proptosis
(Fig. 3). However, gas started collecting again in the retrobulbar and
orbital space; requiring several more decompressions with ﬁne
needle aspiration (x6) and even a gas-ﬂuid exchange. Every time
with partial recovery and relapse shortly after. Without a clear gas
origin and since it seemed to be trapped in the soft tissue; we
decided to enhance its elimination by using HOT. Using the USNAVY
decompression protocol, we started therapy 39 days after the ﬁrst
surgery. HOT proﬁle was 3.0 ATA for 300 minutes with 2 ﬁve-
minute air breaks at 30 minutes intervals, divided in ten sessions
(one per day). Clinical improvement was fast and signiﬁcant with
almost total resolution of proptosis and control of intraocular
pressure (Fig. 4). The HOT protocol was repeated as soon as gas start
collecting again in the retrobulbar and orbital space on CT scans; or
if the patient referred recurrence of the clinical symptoms; twenty
ﬁve additional sessions with the same protocol was needed (35
sessions total). Four months after initial surgery she had total res-
olution of the symptoms and 20/60 of visual capacity. Although
control CT scan still showed 1e1.5 cc of intraconal gas. Eighteen
months later, the patient is 20/60, has an attached retina and total
resolution of the orbital emphysema (Fig. 5).3. Discussion
The kinetic of gas tamponade is complex and has three phases:
bubble expansion (driven by nitrogen [N2]), equilibrium of nitrogen
concentration and bubble clearance [1]. About 10% of the gas
bubble is made of carbon dioxide and oxygen; which remain at
constant concentration at all time. The volume of the bubble
gradually decreases as all the gases are absorbed at the same rate.
Because the longest-acting gas is the slowest to being absorbed, it
controls the rate of bubble clearance in the ﬁnal stage [2,3]. Addi-
tionally, the half-life of the gas bubble is inﬂuenced also by other
factor like the volume of gas injected and concentration, its mo-
lecular weight, diffusion coefﬁcient, water solubility, the intraoc-
ular pressure, the posterior choroid venous concentration of the gas
and the vascular perfusion rate of the choroid [2,10].
According to a basic principle described by John Scott Haldane in
the early 1900s, gas saturation rate varies depending of the tissue
and that N2 is 4.5 times more soluble in fat than in water. This
means that if fat and water are exposed to the same concentration
of N2, the gas will dissolve into both compartments at the same rate
but it will take 4.5 times longer for the N2 in the fat to equilibrate
concentration with the surrounding gas and when it does, the fat
will contain 4.5 times more N2 than the surrounding water [12].
Since most of the tissue in human body has a solubility for N2
similar to water except for fat; the absorption of nitrogen/inert gas
by tissues is determined by the cardiac output. However, it will vary
according to the tissue's speciﬁc blood ﬂow and its fat content.
Usually, adipose tissue has an extremely limited blood ﬂow,
Fig. 1. One week after combine procedure of vitrectomy and scleral buckle; frontal view (A) and lateral view (B). The picture from the outpatient department shows edema of the
superior eyelid and mild redness of the skin, painful to the touch. Bacterial orbital cellulitis was suspected at that time.
Fig. 2. A: Clinical photograph, frontal view; taken at the emergency department at postsurgical day 14. The patient referred an increase in pain, upper eyelid volume and crepitus. B
to D: CT scan of the same day. B shows a bone window, coronal section of the skull; it shows massive amount of gas, surrounding the optic nerve and extraocular muscles. C & D: soft
tissue window, axial sections at two different levels; the images shows gas contained in the upper eyelid, retrobulbar space and anterior chamber.
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very long time to eliminate the absorbed N2 [12,13].
Although the reason of gas expansion and accumulation in
orbital and periorbital adipose tissue in our case is unknown; one
possibility is that instead of SF6, amixture of 18% octaﬂuoropropane
(C3F8) was used. At that dilution, the gas gradually expanded
eventually leaking through sclerotomies as microbubbles toward
the periorbital and intraconal space. Where due to the presence of
orbital fat and slow metabolism of N2; the gas coming from the
vitreous cavity accumulates in great amount without reabsorption.
This would explain the constant recurrences of gas despite
repeatedly decompressions with ﬁne needle aspiration and the
later success of HOT. Despite there is no prior experience regarding
treatment of subcutaneous emphysema with HOT; we observed
that the behavior of the gas was similar than in decompressionsickness. Therefore, using USANAVY decompression protocol was
logic and justiﬁed.
4. Conclusion
The use of gas as tamponade agent in vitreoretinal surgery has
been extensively studied. Although the gas dynamics, expansion
properties, diffusion and resorption in the vitreous cavity is very
well known; a different behavior can be expected if the gas gains
access to the periocular space, mainly due to presence of adipose
tissue and a slow N2 metabolism. Sutureless sclerotomies may be
the escape route of gas. A key step of the surgery is ensuring that
the proper gas and proper dilution is going to be used. Despite the
fact that there are some previous reports of orbital emphysema
secondary to intraocular gas tamponade, the current report
Fig. 3. Upper image (A) was taken after ﬁrst needle decompression. The patient improved mildly. Few days later, gas began collecting again and more decompression were
performed (B). Red arrow indicates the site of repeated needle decompressions.
Fig. 4. A: Clinical photograph, frontal view, taken 24hrs after the ﬁrst hyperbaric treatment. An important decrease in eyelid emphysema can be seen. The patient showed a better
eyelid opening, with less pain and better eye movements. B: 24 h later, the gas started collecting again quickly. C & D: Axial and coronal sections, soft tissue window; obtained after
hyperbaric treatment. The scans shows less amount of gas, although complete resolution was achieve after several hyperbaric sessions.
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Fig. 5. Clinical photograph, frontal view (A) and axial CT scan (B), taken at the patient's last ofﬁce visit (18 months after surgery). The vision was 20/60, full range of ocular
movements, good eyelid opening and no evidence of intraorbital gas.
D.L. Iniesta-Sanchez et al. / American Journal of Ophthalmology Case Reports 1 (2016) 26e3030describe a case of greater severity that did not responded to
traditional management. The successful use of HOT was because it
helped to accelerate N2 elimination from adipose tissue, leading to
a shrinkage of the gas bubble contained in the periocular space,
avoiding further irreversible lesion to structures like the optic
nerve.
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